Press Releases

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE MKT:TRXC), a medical device company that is pioneering the use of robotics and flexible instruments to improve minimally invasive surgery, will ring The Opening Bell® of the New York Stock Exchange (NYSE) on Wednesday, July

Completed Pre-Submission FDA Filing for SurgiBot™ System in March 2014 Announced First Human Cases using Advanced Energy Device in April 2014 Raised $56.4 Million in Gross Proceeds from Public Offering of Common Stock in April and May 2014 Began trading on NYSE MKT under ticker symbol TRXC in April

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE MKT:TRXC), a medical device company that is pioneering the use of flexible instruments and robotics to improve minimally invasive surgery, today announced that the underwriters of its previously announced public offering of

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE MKT:TRXC) announced today that it plans to release first quarter 2014 financial and operating results after the market closes on Wednesday, May 7, 2014 . Todd M. Pope , Chief Executive Officer and Joseph P.

Flexible ligating shears designed for full 360 degree articulation with SPIDER ® Surgical System RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE MKT: TRXC), a medical device company that is pioneering the use of flexible instruments and robotics to improve minimally

Trading on NYSE MKT to Begin April 15, 2014

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (OTCBB:TRXCD), a medical device company that is pioneering the use of flexible instruments and robotics to improve minimally invasive surgery, today announced it intends to offer shares of its common stock in an underwritten public

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (OTCBB:TRXC), a medical device company that is pioneering the use of flexible instruments and robotics to improve minimally invasive surgery, today announced that it has received authorization to list its common shares on the NYSE

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (OTCBB:TRXC), a medical device company that is pioneering the use of flexible instruments and robotics to improve minimally invasive surgery, today announced that it has completed a pre-submission filing with the U.S.

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (OTCBB:TRXC), a medical device company that is pioneering the use of flexible instruments and robotics to improve the experience and outcomes of minimally invasive surgery, today announced it has postponed its Investor & Analyst